Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Friday, April 25 2014 4:59am ET - U.S. Markets open in 4 hours and 31 minutes.
Industry Center
Industry Center > > Merck Serono S.A. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Merck Serono S.A. Company Profile
The fertile minds at Merck Serono help people around the world combat infertility. One of the world's top biotechs, Merck Serono focuses on recombinant genetic engineering to develop drugs. The firm manufactures and markets therapies for neurological, metabolic, endocrinology, oncology, cardiovascular, and growth disorders, among others. It is a leader in reproductive health; flagship drug Gonal-F is a leading infertility product line. Other key products include beta interferon drug Rebif for the treatment of multiple sclerosis (MS) and colorectal and head/neck cancer treatment Erbitux. The company is German drugmaker Merck KGaA's largest subsidiary, responsible for its pharmaceutical research.
Headlines for Merck Serono S.A.
Merck KGaA and Auxogyn Collaborate
- Fri Apr 4
Merck KGaA, Pfizer and Broad Institute Collaborate
- Thu Apr 3
Merck KGaA Starts Study on Tecemotide
- Tue Apr 8
Merck KGaA Enrolls First Patient in Study
- Fri Mar 28
Report: Gulf region still a risk to investors
- Mon Mar 31
First AWARE for All Cancer Clinical Research Education Day Held In Houston
- Tue Apr 1
Contact Information
Address: 9, chemin des Mines
1211 Geneva 20, Switzerland
Phone:+41-22-414-3000
Fax:+41-22-414-2179
Financial Highlights
Fiscal Year End:December
Key People
President: Stefan Oschmann
COO: BelÚn Garijo
SVP Divisional Controlling: Dorothea Wenzel
Industry Information
Sector:
Industry:
Top Competitors
Amgen Inc.
Bayer Pharma AG
Sanofi
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?